Psychiatry Clinical Trials, Long-term Follow-up, and Experience With VMAT2 Inhibitors clinical topic updates By Andrew J. Cutler, MD
Psychiatry Choosing the Right Treatment for Tardive Dyskinesia expert roundtables By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH
Psychiatry Degree of Reversibility of Tardive Dyskinesia expert roundtables By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH
Psychiatry Prevalence Rates of Tardive Dyskinesia With Second-Generation Antipsychotics patient care perspectives By Leslie Citrome, MD, MPH
Psychiatry Older Patients With Tardive Dyskinesia patient care perspectives By Leslie Citrome, MD, MPH
